Skip to main content

Advertisement

Open Peer Review Reports for: Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 May 2019 Submitted Original manuscript
13 May 2019 Reviewed Reviewer Report - Huseyin Eken
16 May 2019 Reviewed Reviewer Report - stefania erra
22 May 2019 Author responded Author comments - Morgane Broudic-Guibert
Resubmission - Version 2
22 May 2019 Submitted Manuscript version 2
27 May 2019 Author responded Author comments - Morgane Broudic-Guibert
Resubmission - Version 3
27 May 2019 Submitted Manuscript version 3
Publishing
30 May 2019 Editorially accepted
25 Jul 2019 Article published 10.1186/s13256-019-2140-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement